Diagenode

>>>   Click for Diagenode’s approach to COVID-19

Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes.


Rao NA, McCalman MT, Moulos P, Francoijs KJ, Chatziioannou A, Kolisis FN, Alexis MN, Mitsiou DJ, Stunnenberg HG

Glucocorticoid receptor (GR) exerts anti-inflammatory action in part by antagonizing proinflammatory transcription factors such as the nuclear factor kappa-b (NFKB). Here, we assess the crosstalk of activated GR and RELA (p65, major NFKB component) by global identification of their binding sites and target genes. We show that coactivation of GR and p65 alters the repertoire of regulated genes and results in their association with novel sites in a mutually dependent manner. These novel sites predominantly cluster with p65 target genes that are antagonized by activated GR and vice versa. Our data show that coactivation of GR and NFKB alters signaling pathways that are regulated by each factor separately and provide insight into the networks underlying the GR and NFKB crosstalk.

Tags
Antibody

Share this article

Published
September, 2011

Source

Products used in this publication

  • Antibody ChIP-seq grade icon
    C15200010-50
    GR Antibody - ChIP-seq Grade
  • Antibody ChIP-seq grade icon
    C15100055-100
    Pol II Antibody - ChIP-seq Grade
  • Antibody ChIP-seq grade icon
    C15200002
    TBP Antibody - ChIP-seq Grade

Events

 See all events

News

 See all news


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.



  ABOUT SSL CERTIFICATES

       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics